Impact BioMedical, Inc.

IBOAMEX • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.46 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
0.45
↘ 0.01 (1.32%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
0.45
↘ 0.01 (1.32%)
🔴Market: CLOSED

Impact BioMedical, Inc. (IBO) trades at $0.46 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jul 17, 2026.

Open?$0.44
High?$0.46
Low?$0.44
Prev. Close?$0.46
Volume?16.8K
Avg. Volume?77.6K
VWAP?$0.45
Rel. Volume?0.22x
Bid / Ask
Bid?$0.44 × 400
Ask?$0.46 × 400
Spread?$0.02
Midpoint?$0.45
Valuation & Ratios
Market Cap?49.6M
Shares Out?107.8M
Float?11.7M
Float %?10.9%
P/E Ratio?N/A
P/B Ratio?4.33
EPS?-$0.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Infectious Disease & Vaccines
Employees
8
Market Cap
49.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.impactbiomedinc.com
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
68
Piotroski F-Score?0/9Weak
Altman Z-Score?7.12Safe
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?4.75%Low
Short Interest?556.5K
Days to Cover?7.4
Free Float11.7M
Avg Daily Volume75.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?0.22Weak
Quick Ratio?0.19Weak
Cash Ratio?0.01Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
41
4.33FAIR▾
P/S?
Peers
100
S&P
3
1,271.74HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-11.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,271.22HIGH▾
Returns & Efficiency
ROE?
S&P
3
-112.2%WEAK▾
ROA?
S&P
3
-75.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$49.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist